EORTC endorses the European Code of Cancer Practice
25 Sep 2020
The European Code of Cancer Practice (The Code), an initiative coordinated by European Cancer organisation, is a citizen and patient-centred manifesto of the core requirements for good clinical cancer practice, in order to improve outcomes for all of Europe’s cancer patients. It has been co-produced by a team of cancer patients, patient advocates and cancer professionals. It has its origins in the European Cancer Patient Bill of Rights, which was launched in the European Parliament on World Cancer Day 2014 and won the prestigious 2018 European Health Award.
The Code focusses on informing and assisting cancer patients at all stages of their cancer journey. It sets out a series of 10 key overarching rights, and in particular, signposting what patients should expect from their health system, in order for them to achieve the best possible outcomes. It is an empowerment tool to ensure the best available care is delivered for European citizens and patients. Each of the 10 overarching rights is linked to three questions that a patient/parent/guardian may choose to ask their healthcare professionals.
“The European Code of Cancer Practice represents an important step forward towards patient centred approaches for research and care, bringing together an unprecedented range of stakeholders sharing the same values to push forward the standards of treatment and care of cancer patients in Europe,” said Dr Denis Lacombe, EORTC Director General. “EORTC contributes, with great enthusiasm and pride, to the coordinated efforts of European Cancer Organisation.”
Read more about the code here.
Related News
Meet the new EORTC Board
9 Jul 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024